Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halliburton Company (HAL) vs Teladoc Health Inc (TDOC) Price & Performance

Halliburton CompanyTrade
Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

Halliburton Company vs Teladoc Health Inc — how do they compare? Halliburton Company trades at $32.44 (market cap $26.45B), while Teladoc Health Inc trades at $5.54 (market cap $1.01B). The key difference: Halliburton Company is far larger — about 26.2× Teladoc Health Inc's market cap, and Halliburton Company pays a 2.14% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halliburton Company for 89 Days and Teladoc Health Inc for 39 Days on average.

HALTDOC
Market Cap
$26.45B$1.01B
Volume
11,229,2743,622,440
Sector
EnergyHealth
52-Week High
$42.98$9.72
52-Week Low
$21.82$4.47
Typical Hold Time
89 Days39 Days
Enterprise Value
$32.60B$1.27B
Dividend Yield
2.14%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Halliburton Company

Halliburton (HAL) trades at $32.57, down 0.46% on the day, amid a bearish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Recent news highlights expansion in Venezuela and a major contract win in Cyprus, signaling growth initiatives. Financials show solid profitability with a net income margin of 7.16% and a P/E ratio of 16.62, though 2025 revenue dipped slightly to $22.18 billion.

The outlook is supported by strong analyst consensus with a $43.11 price target and 73% buy ratings, but risks include oil price volatility and execution challenges in new markets. Cash flow trends have been mixed, with 2025 net cash flow negative $412 million, though 2026 projects a return to positive territory.

Teladoc Health Inc

Teladoc Health (TDOC) trades at $5.54, down 3.99% in the latest session, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with oversold conditions while fundamentals reveal a mixed picture - strong gross margins of 68.97% but persistent net losses. Recent management changes and legal investigations add uncertainty, though the company maintains solid cash flow from operations of $294.36 million.

TDOC presents a high-risk opportunity with significant upside potential given the $8.83 consensus price target, representing 59% upside. However, continued net losses, negative cash flow trends, and competitive pressures in telehealth create substantial execution risk. The stock's current valuation at 0.4x sales appears attractive if the company can achieve profitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HAL
79% Buy21% Sell
Avg holding period · 89 Days
TDOC

No sentiment data available yet.

About Halliburton Company

Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.

Read more on HAL →

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →